Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-11-13
1999-06-08
Jacobson, Dian C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
435 691, 435 696, 435 697, 514 8, 514834, 530350, 530383, 930100, A61K 3800, A61K 3514, C12P 2104, C12P 2106
Patent
active
059104813
ABSTRACT:
Hybrid proteins which affect blood coagulation comprise a region from a donor anticoagulant or antithrombotic protein, and the resulting hybrid protein has a modified biological activity. Information concerning the hybrid proteins implicates DNA sequences encoding the proteins and hosts, including transgenic animals, that possess these DNA sequences; antibodies directed against hybrid proteins; methods of modifying the properties of proteins; and treatment methods employing hybrid proteins.
REFERENCES:
patent: 4868112 (1989-09-01), Toole
patent: 5286487 (1994-02-01), Vallee et al.
patent: 5358932 (1994-10-01), Foster et al.
patent: 5364771 (1994-11-01), Lollar et al.
Donath et al., Activation and Limited Proteolysis of Human Blood Coagulation Factor VIII, pp. 33-48 (1995).
Mertens et al., British Journal of Haematology 85: 133-142 (1993).
Voorberg et al., Journal of Biological Chemistry 271(35): 20985-20988 (1996).
Aledort, Sem. Hematol. 30(2): 7-9 (1993).
Bode et al., EMBO J. 8(11): 3467-75 (1989).
Brackman et al., Lancet 2: 933 (1977).
Chibber et al., Biochemistry 24: 3429-34 (1985).
Coughlin et al., J. Clin. Invest. 89:351-55 (1992).
Culver et al., Science 256: 1550-52 (1992).
Davie et al., Science 145: 1310-12 (1964).
Davie et al., Biochem. 30(43): 10363-70 (1991).
Eaton et al., Biochemistry 25(26): 8343-47 (1986).
Eaton et al., Biochem. 25: 505-12 (1986).
Esmon, Thromb. Haemost. 70(1): 29-35 (1993).
Fay et al., Thromb. Haemost. 70: 63-67 (1993).
Foss et al., Blood 84(6): 1765-74 (1994).
Gailani et al., Science 253: 909-12 (1991).
Graham et al., Virology 52: 456-67 (1973).
Grutter et al., EMBO J. 9(8): 2361-65 (1990).
Hortin et al., Biochem. Biophys. Res. Commun. 169(2): 437-442 (1990).
Huber et al., Biochem. 28(23): 8951-66 (1989).
Jackson et al., Ann. Rev. Biochem. 49: 765 (1980).
Jesty, Haemostasis 21: 208-18 (1991).
Johnson et al., "Peptide Tum Mimetics" in Biotechnoloy and Pharmacy.
Kane et al., Blood 71(3): 539-55 (1988).
Kreitman et al., Biochemistry 33: 11637-44 (1994).
Lenting et al., J. Biol. Chem. 269: 7150-55 (1994).
Leyte et al., J. Biol. Chem. 266(2): 740-46 (1991).
Leyte et al., J. Biochem. 263: 187-94 (1989).
Liu et al., J. Biol. Chem. 266(26): 16977-80 (1991).
Lollar et al., J. Biol. Chem. 263(21): 10451-55 (1988).
Lollar et al., Biochemistry 28: 666-74 (1989).
MacFarlane, Nature 202: 498-99 (1964).
Mann et al., Blood 76(1): 1-16 (1990).
Mathews et al., Biochemistry 33: 3266-79 (1994).
Mertens et al., Brit. J. Haematol. 85: 1-10 (1993).
Mertens et al., J. Biochem. 223: 599-605 (1984).
Michnik et al., J. Biol. Chem. 269(31): 20095-102 (1994).
Mikkelsen et al, Biochemistry 30: 1533-37 (1991).
Neuenschwander et al., Analyt. Biochem. 184: 347-52 (1990).
Pittman et al., Biochemistry 31(13): 3315-25 (1992).
Rosenberg et al., Human Gene Therapy 3: 57-75 (1992).
Rydel et al., Science 249: 277-80 (1990).
Saragovi et al., Science 253: 792-95 (1991).
Sarver et al., DNA 6(6):553-64 (1987).
Skrzypczak-Jankun et al., J. Mol. Biol. 206: 755-57 (1989).
Stubbs et al., Thromb. Res. 69: 1-58 (1993).
te Riele et al., Nature 348: 649-51 (1990).
Toole et al., Proc. Nat'l Acad. Sci. USA 83: 5939-42 (1986).
Tsiang et al., Biochemistry 29: 10602-12 (1990).
Van Deerlin et al., J. Biol. Chem. 266(30): 20223-31 (1991).
Vu et al., Nature 353: 674-77 (1991).
Yelton et al., Ann. Rev. Biochem. 50: 657-680 (1981).
Immuno AG
Jacobson Dian C.
Slobodyansky Elizabeth
LandOfFree
Hybrid proteins with modified activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybrid proteins with modified activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid proteins with modified activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1683325